Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India

BMC Public Health

Mark Nichter⁴  PS Sarma³  G Vijayakumar²  Meena Daivadanam³  GK Mini¹  KR Thankappan³ 

[1] Quit Tobacco India Project, Achutha Menon Centre for Health Science Studies, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, 695 011, India;Medical Trust Hospital, Pandalam, Pathanamthitta, Kerala, India;Achutha Menon Centre for Health Science Studies, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, 695 011, India;Family Medicine and Public Health, University of Arizona, Tucson, Arizona, USA

关键词: India;    Kerala;    Counseling;    Smoking cessation;    Diabetes;   

Others  :  1162632
DOI  :  10.1186/1471-2458-13-47

 received in 2012-07-16, accepted in 2013-01-15,  发布年份 2013

【 摘 要 】

Background

India has the second largest diabetic population (61 million) and tobacco users (275 million) in the world. Data on smoking cessation among diabetic patients are limited in low and middle income countries. The objective of the study was to document the effectiveness of diabetic specific smoking cessation counseling by a non-doctor health professional in addition to a cessation advice to quit, delivered by doctors.

Methods

In our parallel-group randomized controlled trial, we selected 224 adult diabetes patients aged 18 years or older who smoked in the last month, from two diabetes clinics in South India. Using a computer generated random sequence with block size four; the patients were randomized equally into intervention-1 and intervention-2 groups. Patients in both groups were asked and advised to quit smoking by a doctor and distributed diabetes specific education materials. The intervention-2 group received an additional diabetes specific 30 minutes counseling session using the 5As (Ask, Advise, Assess, Assist and Arrange), and 5 Rs (Relevance, Risks, Rewards, Roadblocks and Repetition) from a non-doctor health professional. Follow up data were available for 87.5% of patients at six months. The Quit Tobacco International Project is supported by a grant from the Fogarty International Centre of the US National Institutes of Health (RO1TW005969-01).

The primary outcomes were quit rate (seven day smoking abstinence) and harm reduction (reduction of the number of cigarettes / bidis smoked per day > 50% of baseline use) at six months.

Results

In the intention to treat analysis, the odds for quitting was 8.4 [95% confidence interval (CI): 4.1-17.1] for intervention-2 group compared to intervention-1 group. Even among high level smokers the odds of quitting was similar. The odds of harm reduction was 1.9 (CI: 0.8-4.1) for intervention-2 group compared to intervention-1 group.

Conclusions

The value addition of culturally sensitive diabetic specific cessation counseling sessions delivered by non-doctor health professional was an impressive and efficacious way of preventing smoking related diabetic complications.

Trial Registration

Clinical Trial Registry of India (CTRI/2012/01/002327)

【 授权许可】

   
2013 Thankappan et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Registrar General of India: Census of India. 2011. http://www.censusindia.gov.in webcite
• [2]International Diabetes Federation (IDF): IDF Diabetes atlas. 5th edition. Brussels: International Diabetes Federation; 2011.
• [3]International Institute for Population Sciences (IIPS): Global Adult Tobacco Survey India (GATS India), 2009–2010. Mumbai: Ministry of Health and Family Welfare, Government of India, New Delhi, ; 2010.
• [4]Jha P, Jacob B, Gajalakshmi V, Gupta PC, Dhingra N, Kumar R, Sinha DN, Dikshit RP, Parida DK, Kamadod R, Boreham J, Peto R: RGI-CGHR Investigators: a nationally representative case–control study of smoking and death in India. N Engl J Med 2008, 358:1137-1147.
• [5]Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J: Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007, 298:2654-2664.
• [6]Eliasson B: Cigarette smoking and diabetes. Prog Cardiovasc Dis 2003, 45:405-413.
• [7]Foy CG, Bell RA, Farmer DF, Goff DC Jr, Wagenknecht LE: Smoking and incidence of diabetes among U.S. adults: findings from the insulin resistance atherosclerosis study. Diabetes Care 2005, 28:2501-2507.
• [8]International Diabetes Federation: Position statement-diabetes and tobacco use. 2003. http://www.idf.org/position-statement-diabetes-and-tobacco-use webcite
• [9]American Diabetes Association: Smoking and diabetes: position statement. Diabetes Care 2004, 27:S74-S75.
• [10]Al-Delaimy WK, Manson JE, Solomon CG, Kawachi I, Stampfer MJ, Willett WC, Hu FB: Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med 2002, 162:273-279.
• [11]Giorda CB, Avogaro A, Maggini M, Lombardo F, Mannucci E, Turco S, Alegiani SS, Raschetti R, Velussi M, Ferrannini E, DAI Study Group: Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke 2007, 38:1154-1160.
• [12]Paetkau ME, Boyd TA, Winship B, Grace M: Cigarette smoking and diabetic retinopathy. Diabetes 1977, 26:46-49.
• [13]Eason SL, Petersen NJ, Suarez-Almazor M, Davis B, Collins TC: Diabetes mellitus, smoking, and the risk for asymptomatic peripheral arterial disease: whom should we screen? J Am Board Fam Pract 2005, 18:355-361.
• [14]Peters DH, Rao KS, Fryatt R: Lumping and splitting: the health policy agenda in India. Health Policy Plan 2003, 18:249-260.
• [15]Thankappan KR, Shah B, Mathur P, Sarma PS, Srinivas G, Mini GK, Daivadanam M, Soman B, Vasan RS: Risk factor profile for chronic non-communicable diseases: results of a community-based study in Kerala. India. Indian J Med Res 2010, 131:53-63.
• [16]Reddy KS, Prabhakaran D, Chaturvedi V, Jeemon P, Thankappan KR, Ramakrishnan L: Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. Bull World Health Organ 2006, 84:461-469.
• [17]Thresia CU, Thankappan KR, Nichter M: Smoking cessation and diabetes control in Kerala, India: an urgent need for health education. Health Educ Res 2009, 24:839-845.
• [18]Hohanson JM, Anderson RL, Hennrikus DJ, Lando HA, Kendall DM: Integrated tobacco cessation counseling in a diabetes self-management training Program: a randomized trial of diabetes and reduction of tobacco. Diabetes Educ 2006, 32:562-570.
• [19]Ng N, Nichter M, Padmawati RS, Prabandari YS, Muramoto M, Nichter M: Bringing smoking cessation to diabetes clinics in Indonesia. Chronic Illn 2010, 6:125-135.
• [20]Rao M, Rao KD, Kumar AK, Chatterjee M, Sundararaman T: Human resources for health in India. Lancet 2011, 377:587-598.
• [21]Nichter M, Project Quit Tobacco International Group: Introducing tobacco cessation in developing countries: an overview of Project Quit Tobacco International. Tob Control 2006, 15:12-17.
• [22]Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz N, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, Henderson PN: Treating tobacco use and dependence: 2008 Update: Quick Reference Guide for Clinicians. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service; 2009.
• [23]Ramachandran A, Ma RC, Snehalatha C: Diabetes in Asia. Lancet 2010, 375:408-418.
• [24]Aravindan KP: Kerala Padanam (in Malayalam). Kozhikodu, India: Kerala Sastra Sahitya Parishad; 2006.
• [25]Cox K: Smoking cessation buddies in COPD. Nurs Times 2011, 107:22-23.
• [26]Pokhrel BR, Thankappan KR, Mini GK, Sarma PS: Tobacco use among health professionals and their role in tobacco cessation in Nepal. Prev Control 2006, 2:117-125.
• [27]Thankappan KR, Thresia CU: Tobacco use and social status in Kerala. Indian J Med Res 2007, 126:300-308.
• [28]Steinberg MB, Schmelzer AC, Lin PN, Garcia G: Smoking as a chronic disease. Curr Cardio Risk Rep 2010, 4:413-420.
• [29]SRNT Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2004, 4:149-159.